Ahrin Koppel

638 total citations
9 papers, 514 citations indexed

About

Ahrin Koppel is a scholar working on Hematology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ahrin Koppel has authored 9 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ahrin Koppel's work include Acute Myeloid Leukemia Research (4 papers), Genetic Neurodegenerative Diseases (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Ahrin Koppel is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Genetic Neurodegenerative Diseases (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Ahrin Koppel collaborates with scholars based in United States and Germany. Ahrin Koppel's co-authors include Ellen M. Carpenter, Hadi Zanjani, Marie‐Françoise Chesselet, Scott Zeitlin, E. Gruen, Mauricio E. Vargas, Argiris Efstratiadis, Raymond S Hurst, Carlos Cepeda and Gloria J. Klapstein and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Experimental Neurology.

In The Last Decade

Ahrin Koppel

9 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahrin Koppel United States 7 392 338 215 50 28 9 514
Beena T. Koshy United States 4 608 1.6× 681 2.0× 179 0.8× 12 0.2× 12 0.4× 4 770
David Nonis Germany 10 180 0.5× 257 0.8× 95 0.4× 19 0.4× 22 0.8× 12 371
Pui Pik Law United Kingdom 8 130 0.3× 275 0.8× 40 0.2× 22 0.4× 46 1.6× 10 383
Heliane Guerra Serra Brazil 5 308 0.8× 302 0.9× 62 0.3× 5 0.1× 14 0.5× 7 368
Brigitte Stecher Germany 12 131 0.3× 230 0.7× 129 0.6× 9 0.2× 36 1.3× 14 393
Liudmila Romanova United States 9 77 0.2× 198 0.6× 39 0.2× 9 0.2× 38 1.4× 21 323
Aki Sato Japan 5 260 0.7× 250 0.7× 105 0.5× 4 0.1× 33 1.2× 8 379
J. Vesa Finland 11 226 0.6× 349 1.0× 108 0.5× 4 0.1× 173 6.2× 12 563
Elisabeth Rossaert Belgium 8 86 0.2× 186 0.6× 113 0.5× 7 0.1× 33 1.2× 9 295
Christine M. Rostosky Germany 5 68 0.2× 153 0.5× 37 0.2× 24 0.5× 72 2.6× 5 312

Countries citing papers authored by Ahrin Koppel

Since Specialization
Citations

This map shows the geographic impact of Ahrin Koppel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahrin Koppel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahrin Koppel more than expected).

Fields of papers citing papers by Ahrin Koppel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahrin Koppel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahrin Koppel. The network helps show where Ahrin Koppel may publish in the future.

Co-authorship network of co-authors of Ahrin Koppel

This figure shows the co-authorship network connecting the top 25 collaborators of Ahrin Koppel. A scholar is included among the top collaborators of Ahrin Koppel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahrin Koppel. Ahrin Koppel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Koppel, Ahrin, et al.. (2020). Addressing rural disparities in cancer care via telehealth.. Journal of Clinical Oncology. 38(15_suppl). e19090–e19090. 6 indexed citations
3.
Koppel, Ahrin & Gary J. Schiller. (2008). Myelodysplastic syndrome: An update on diagnosis and therapy. Current Hematologic Malignancy Reports. 4(1). 10–16. 3 indexed citations
4.
Koppel, Ahrin & Gary J. Schiller. (2008). Myelodysplastic syndrome: An update on diagnosis and therapy. Current Oncology Reports. 10(5). 372–378. 3 indexed citations
5.
Koppel, Ahrin, et al.. (2007). Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria. Transfusion. 47(10). 1902–1904. 27 indexed citations
6.
Gery, Sigal, Sakae Tanosaki, Wolf‐K. Hofmann, Ahrin Koppel, & H. Phillip Koeffler. (2005). C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation. Oncogene. 24(9). 1589–1597. 57 indexed citations
7.
Menalled, Liliana, Hadi Zanjani, Larami Mackenzie, et al.. (2000). Decrease in Striatal Enkephalin mRNA in Mouse Models of Huntington’s Disease. Experimental Neurology. 162(2). 328–342. 101 indexed citations
8.
Levine, Michael S., Gloria J. Klapstein, Ahrin Koppel, et al.. (1999). Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. Journal of Neuroscience Research. 58(4). 515–532. 282 indexed citations
9.
Levine, Michael, Gloria J. Klapstein, Ahrin Koppel, et al.. (1999). Enhanced sensitivity to N‐methyl‐D‐aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. Journal of Neuroscience Research. 58(4). 515–532. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026